Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and ...

Good morning and welcome to PDS Biotech's 4th quarter in full year 2024 earnings conference call. Thank you, operator. Good morning, everyone, and welcome to PDS Biotech's 2024 results and clinical ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...

Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...

UVU Bio aims to provide lab infrastructure, technical expertise and commercial guidance to help scientists become entrepreneurs.

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement ...

The National Institutes of Health has been integral to scientific progress in treating countless human diseases. Without its support, patients will ultimately pay the price.

Fast science’ can damage research integrity – just as fast food can damage your health. ‘Slow science’ offers an alternative ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...